ACAD – ACADIA Pharmaceuticals Inc.
Name :
Sector :
Industry:
Mark. Cap: $0.0000
EPSttm :
Float Short %
6.52
Margin Of Safety %
35
Put/Call OI Ratio
0.36
EPS Next Q Diff
-0.18
EPS Last/This Y
1.06
EPS This/Next Y
0.09
Price
17.57
Target Price
24.95
Analyst Recom
1.89
Performance Q
16.82
Relative Volume
1.08
Beta
0.37
Ticker: ACAD
20 items
«
‹
of 1
›
»
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
---|---|---|---|---|---|
2024-12-19 | ACAD | 16.74 | 0.40 | 16.18 | 27063 |
2024-12-20 | ACAD | 16.88 | 0.35 | 1.14 | 26218 |
2024-12-23 | ACAD | 17.2 | 0.55 | 0.09 | 10054 |
2024-12-24 | ACAD | 17.07 | 0.53 | 0.49 | 10231 |
2024-12-26 | ACAD | 17.39 | 0.54 | 1.05 | 10329 |
2024-12-27 | ACAD | 16.96 | 0.59 | 2.63 | 11673 |
2024-12-30 | ACAD | 16.71 | 0.59 | 3.96 | 11730 |
2024-12-31 | ACAD | 18.35 | 0.62 | 0.01 | 12003 |
2025-01-02 | ACAD | 18.66 | 0.35 | 0.05 | 17770 |
2025-01-03 | ACAD | 18.41 | 0.34 | 1.36 | 18425 |
2025-01-06 | ACAD | 17.46 | 0.37 | 0.82 | 19397 |
2025-01-07 | ACAD | 17.4 | 0.37 | 0.06 | 19587 |
2025-01-08 | ACAD | 17.62 | 0.36 | 0.05 | 19632 |
2025-01-09 | ACAD | 17.6 | 0.36 | 0.05 | 19632 |
2025-01-10 | ACAD | 17.25 | 0.36 | 0.28 | 19810 |
2025-01-13 | ACAD | 17.88 | 0.36 | 0.09 | 19758 |
2025-01-14 | ACAD | 16.92 | 0.36 | 0.11 | 19918 |
2025-01-15 | ACAD | 17.51 | 0.36 | 0.37 | 19939 |
2025-01-16 | ACAD | 17.52 | 0.36 | 0.08 | 20042 |
2025-01-17 | ACAD | 17.57 | 0.36 | 0.02 | 20058 |
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
20 items
«
‹
Current Page1 of 1
›
»
20 items
«
‹
of 1
›
»
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
---|---|---|---|---|---|
2024-12-19 | ACAD | 16.73 | -18.7 | 49.3 | 0.71 |
2024-12-20 | ACAD | 16.88 | -18.7 | 53.2 | 0.71 |
2024-12-23 | ACAD | 17.17 | -24.6 | 55.0 | 0.69 |
2024-12-24 | ACAD | 17.07 | -24.6 | 50.2 | 0.69 |
2024-12-26 | ACAD | 17.37 | -24.6 | 54.9 | 0.69 |
2024-12-27 | ACAD | 16.96 | -24.6 | 46.7 | 0.69 |
2024-12-30 | ACAD | 16.69 | -24.6 | 48.3 | 0.69 |
2024-12-31 | ACAD | 18.36 | -24.6 | 71.5 | 0.69 |
2025-01-02 | ACAD | 18.66 | -24.6 | 54.7 | 0.69 |
2025-01-03 | ACAD | 18.39 | -24.6 | 48.5 | 0.69 |
2025-01-06 | ACAD | 17.44 | -24.6 | 41.1 | 0.69 |
2025-01-07 | ACAD | 17.39 | -24.6 | 50.6 | 0.69 |
2025-01-08 | ACAD | 17.60 | -24.6 | 53.8 | 0.69 |
2025-01-09 | ACAD | 17.60 | -24.6 | 51.4 | 0.69 |
2025-01-10 | ACAD | 17.25 | -24.6 | 47.5 | 0.69 |
2025-01-13 | ACAD | 17.90 | -24.6 | 58.8 | 0.69 |
2025-01-14 | ACAD | 16.89 | -24.6 | 40.2 | 0.69 |
2025-01-15 | ACAD | 17.51 | -24.6 | 58.7 | 0.69 |
2025-01-16 | ACAD | 17.52 | -24.6 | 51.5 | 0.69 |
2025-01-17 | ACAD | 17.57 | -24.1 | 51.9 | 0.69 |
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
20 items
«
‹
Current Page1 of 1
›
»
20 items
«
‹
of 1
›
»
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
---|---|---|---|---|
2024-12-19 | ACAD | -3.48 | -4.75 | 6.03 |
2024-12-20 | ACAD | -3.48 | -4.75 | 6.03 |
2024-12-23 | ACAD | -3.46 | -4.76 | 6.03 |
2024-12-24 | ACAD | -3.46 | -4.76 | 6.03 |
2024-12-26 | ACAD | -3.50 | -4.76 | 5.70 |
2024-12-27 | ACAD | -3.48 | -4.76 | 5.70 |
2024-12-30 | ACAD | -3.57 | -4.70 | 5.70 |
2024-12-31 | ACAD | -3.57 | -4.70 | 5.70 |
2025-01-02 | ACAD | -3.18 | -4.70 | 5.70 |
2025-01-03 | ACAD | -3.48 | -4.70 | 5.70 |
2025-01-06 | ACAD | -3.53 | -4.81 | 5.70 |
2025-01-07 | ACAD | -3.53 | -4.81 | 5.70 |
2025-01-08 | ACAD | -3.48 | -4.81 | 5.70 |
2025-01-09 | ACAD | -3.48 | -4.81 | 5.70 |
2025-01-10 | ACAD | -3.48 | -4.81 | 5.70 |
2025-01-13 | ACAD | -3.48 | -4.87 | 6.52 |
2025-01-14 | ACAD | -3.48 | -4.87 | 6.52 |
2025-01-15 | ACAD | -3.48 | -4.87 | 6.52 |
2025-01-16 | ACAD | -3.48 | -4.87 | 6.52 |
2025-01-17 | ACAD | -3.48 | -4.87 | 6.52 |
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
20 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
0.2
Avg. EPS Est. Current Quarter
0.21
Avg. EPS Est. Next Quarter
0.02
Insider Transactions
-3.48
Institutional Transactions
-4.87
Beta
0.37
Average Sales Estimate Current Quarter
278
Average Sales Estimate Next Quarter
237
Fair Value
23.75
Quality Score
86
Growth Score
59
Sentiment Score
34
Actual DrawDown %
70.1
Max Drawdown 5-Year %
-77.2
Target Price
24.95
P/E
22.74
Forward P/E
23.21
PEG
P/S
3.15
P/B
5.06
P/Free Cash Flow
14.43
EPS
0.77
Average EPS Est. Cur. Y
0.69
EPS Next Y. (Est.)
0.78
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
13.83
Relative Volume
1.08
Return on Equity vs Sector %
3.2
Return on Equity vs Industry %
15.8
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.02
EBIT Estimation
51.9
stock quote shares ACAD – ACADIA Pharmaceuticals Inc. Stock Price stock today
news today ACAD – ACADIA Pharmaceuticals Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch ACAD – ACADIA Pharmaceuticals Inc. yahoo finance google finance
stock history ACAD – ACADIA Pharmaceuticals Inc. invest stock market
stock prices ACAD premarket after hours
ticker ACAD fair value insiders trading